G. Steven Burrill

Welcome from the CEO

Flash required to view this video. Download the latest version here

 G. Steven Burrill 
TJOLS available online
 

Podcast

Hear 
G. Steven Burrill's vision of healthcare in the year 2020 in a special podcast from The Journal of Life Sciences.
Hear the podcast 
Burrill & Company is a life sciences merchant bank focused exclusively on companies involved in biotechnology, pharmaceuticals, diagnostics, devices, human healthcare and related medical technologies, nutraceuticals and wellness, agricultural biotechnology, and industrial biotechnology (biomaterials/bioprocesses) with $950 million under management.

Burrill Venture Capital

Burrill's venture funds capitalize on our unique investment platform, the opportunities created by today’s technologic revolution, and capital market inefficiency.


Learn more about Burrill Venture Capital
Learn more about Burrill Venture Capital

Burrill Private Equity

Our private equity team focuses on undervalued small/midcap public companies and selected buy-outs and spin-outs.


Learn more about Burrill Private Equity
Learn more about Burrill Private Equity

Burrill Merchant Banking

Burrill Merchant Banking assists life science companies  identify, negotiate and close strategic partnerships, M&A transactions and financings.


Learn more about  Burrill Merchant Banking
Learn more about Burrill Merchant Banking

Burrill International

Burrill & Company has established a multicultural and multilingual team, with extensive international business experience, to bridge the different regions of the world.


Learn more about Burrill International
Learn more about Burrill International

Burrill Publications & Resources

State-of-the-Industry at BIO 2008 presentation: G. Steven Burrill spoke about the future of the biotechnology industry. To obtain his slide presentation order here.


Order now
Order now

Save the Date!

The Stem Cell Meeting will  be held in San Francisco September 16-17, 2008. This conference will examine the critical scientific, policy and business issues facing stem cell research, medicine and investment.


Burrill Conferences & Special Events